Abstract. Bone marrow and peripheral blood from patients who had received chloroquine phosphate were studied to determine the effect of this drug on the ultrastructure of cytoplasmic granules in leukocytes. Neutrophils from approximately one-half of the patients who were treated developed abnormal cytoplasmic granules. Vacuolar, lamellar, and particulate components within abnormal, large granules were present in myelocytes from certain patients who received chloroquine therapy. Mature neutrophils and lymphocytes from these patients showed variable numbers of large, membrane-bounded structures containing myelin figures. Cytoplasmic granules in eosinophilic myelocytes from patients treated with chloroquine did not contain the usual crystalloid structure, but instead contained small whorls of osmiophilic material. The granules in abnormal mature eosinophils were replaced by large vacuoles which contained amorphous material. The abnormal granules seen in these various white cells after chloroquine therapy may either reflect defective granule formation or autophagy.
Introduction
Previous work by others has helped to establish the true nature of cytoplasmic granules normally found within leukocytes. Extensive biochemical and functional studies have demonstrated that such cytoplasmic granules are lysosomes (1, 2) .
Although stained smears of human leukocytes have been studied for approximately 100 years, very little is known about abnormal leukocyte granulation. Abnormal granules in human leukocytes have been observed in both hereditary and acquired disorders. In the case of the latter, the etiology is diverse and the leukocyte abnormality is often reversible. In preparations stained by the Wright-Giemsa method normal human neutrophil granules are pink-to-purple structures approx-granules. The ultrastructure of any type of abnormal acquired leukocyte granulation has not been described and the pathophysiology of the changes is unknown.
During the course of a study on human marrow, abnormal, large basophilic granules in neutrophilic leukocytes were noted on a smear from a patient who received a course of chloroquine phosphate, 7-chloro-4-( 4-diethylamino -1 -methylbutylamino) quinoline phosphate, therapy for sarcoidosis. "Toxic" granules have been noted previously on blood smears from patients who have been treated with chloroquine (3) . This communication will describe the ultrastructural changes in marrow and peripheral blood leukocytes from patients who received chloroquine phosphate therapy.
Methods and Materials
Administration of drug. Six patients with sarcoidosis were given 250-500 mg chloroquine phosphate (Winthrop Laboratories, N. Y.) orally, daily for periods of 2-6 months. Diagnosis was confirmed in all patients in the study by positive Kveim tests and clinical history compatible with sarcoidosis.
Six patients with sarcoidosis who received no therapy were also studied.
Preparation of tissue specimens. Serial samples of 1)eril)heral blood were collected from all patients before, (luring, and after treatment with chloroquine and were prepared for electron microscopy in the following manner.
Blood was collected into heparinized capillary tubes (Yankee, Clay-Adams, N. Y.) and centrifuged at 2500 g for 15 min. The glass capillary tube was broken above the buffy coat layer; the buffy coat was then expressed into fixative.
Bone marrow was aspirated from the posterior iliac crest of one patient during and 2 months after a course of chloroquine therapy. The marrow was collected into a syringe coated with normal saline which contained heparin (Panheparin, Abbot, Chicago, Ill.) in a final concentration of 1.5 mg/ml. The marrow suspension was then centrifuged at 250 g for 5 min. Small particles of marrow which contained fat rose to the top of the plasma, were aspirated, and then were either prepared for light microscopy or fixed for electron microscopy.
Light nmicroscopy. Smears of both peripheral blood and bone marrow particles were air-dried and stained with Wright-Giemsa stain.
Fixation for electron microscopy. (Fig. 1 ).
The cytoplasmic granules appeared as round, oblong, or biconcave electron-opaque structures which varied in size and shape. They were membrane bounded and for the most part did not possess any internal structure, but occasionally contained a crystalloid inclusion. Variable amounts of glycogen, sparse amounts of rough endoplasmic reticulum, and occasional mitochondria were present in the cytoplasm. On a stained smear the mature cells showed typical small 0.2-0.5 u pinkto-purple granules (see insert, Fig. 1 ). The ultrastructure of an abnormal mature neutrophil from peripheral blood of a patient treated with chloroquine is seen in Fig. 2 Fig. 2 . X 1900.
normal persons contained membrane-bounded cytoplasmic granules which did not have any internal structure (Fig. 3) . Smooth and rough endoplasmic reticulum, often showing dilated cisternae, was widely distributed in the cytoplasm. The Golgi complex occupied a relatively small area in human myelocytes; vesicular, vacuolar, and lamellar elements were seen. A myelocyte from a patient who was receiving chloroquine therapy is shown in Fig. 4 . The affected granules were abnormally large and contained internal structure which consisted of vacuolar, lamellar, and par- ticulate inclusions. In some instances these components appeared fused to the periphery of the abnormal granule. Another abnormal myelocyte is shown in Fig. 5 . Several granules had incorporated vacuolar elements and there was some evidence of early myelin figure formation.
Eosinophils. Normal mature eosinophils from untreated patients with sarcoidosis or from normal persons contained cytoplasmic granules with the characteristic internal crystalloid (6) . Normal eosinophilic myelocytes contained two types of granules: those without any internal structure and those with a crystalloid inclusion.
The ultrastructure of mature, circulating eosinophils from certain sarcoidosis patients treated with chloroquine was profoundly affected. The abnor- On the basis of the findings in peripheral blood and bone marrow there are three possible cell mechanisms alone or in combination which could produce the abnormal changes: phagocytosis, an abnormality in cytoplasmic granule formation, or autophagy. The cell process which contributes to the change is likely one to which the myelocyte is most susceptible. In that case, phagocytosis could be excluded as the responsible process, since myelocytes are known not to engage in phagocytosis of exogenous material (13) . On the other hand, the changes seen in early myelocytes are compatible with an effect of the drug on cytoplasmic granule formation, but no direct evidence for such an effect is available (14) . The observed changes could also arise by autophagy, perhaps occurring in response to a damaging effect of the drug on some cytoplasmic component.
In other words, the abnormal cytoplasmic granules in myelocytes and mature neutrophils may represent either primary lysosomes arising from defective granule formation or secondary lysosomes resulting from an autophagic process. A meaningful answer could be obtained only if a recognizable organelle, such as mitochondrion, was found within vacuoles observed in affected myelocytes. Autophagy then could be clearly implicated as the process involved. In the specimens examined there were no recognizable cytoplasmic organelles within abnormal vacuoles or granules. In the case of the neutrophil, electron microscopic histochemistry for acid phosphatase is of little help in distinguishing between primary and secondary lysosomes.
Eosinophils from certain patients treated with chloroquine also show structural abnormalities in immature cells. Many cytoplasmic granules in very early myelocytes are normal; abnormal cytoplasmic granules become prominent as the cells mature. The more mature cells contain a marked reduction in content of the characteristics, normal cytoplasmic granule with an internal crystalloid. Instead, the cytoplasm is filled with vacuoles which contain amorphous material. The observed changes may represent an arrest in granule formation or alteration of normal cytoplasmic granules after they are formed.
Normal lymphocytes are known not to take up exogenous material by either phagocytosis or pinocytosis. In addition, these cells normally contain few if any cytoplasmic granules. Histochemistry at the ultrastructural level helped to establish that the myelin figures which may appear in lympho-cytes of persons given chloroquine were positive for acid phosphatase. Autophagy is then the most reasonable explanation for the origin of these abnormal structures.
The influence of these ultrastructural changes in cytoplasmic granules on cell function is unknown. Clinically the patients were asymptomatic; they did not report intercurrent infections, and healing from skin biopsy sites was unimpaired. Approximately one-half of the patients treated with chloroquine phosphate did not show changes in their leukocytes; the reason for this is not apparent at the present time.
The morphologic changes produced by chloroquine in leukocytes and secretory cells of other species as well as the characteristics of the chloroquine effect with in vitro cell systems will be described in subsequent communications. The ultrastructural changes described here characterize one form of acquired abnormal ("toxic") leukocyte granulation. The ultrastructure of other forms of acquired leukocyte granulation is unknown. The cell mechanisms responsible for abnormal leukocyte granulations including those in such hereditary disorders as the Chediak-Higashi syndrome and Alders anomaly remain to be investigated.
